Drug Shortage Report for AURO-OLMESARTAN HCTZ
Report ID | 106080 |
Drug Identification Number | 02476487 |
Brand name | AURO-OLMESARTAN HCTZ |
Common or Proper name | Hydrochlorothiazide; Olmesartan Medoxil |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
Strength(s) | 12.5MG 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-11-15 |
Estimated end date | 2024-09-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-08-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v39 | 2024-08-13 | French | Compare |
v38 | 2024-08-13 | English | Compare |
v37 | 2024-07-29 | French | Compare |
v36 | 2024-07-29 | English | Compare |
v35 | 2024-07-15 | French | Compare |
v34 | 2024-07-15 | English | Compare |
v33 | 2024-05-30 | French | Compare |
v32 | 2024-05-30 | English | Compare |
v31 | 2024-04-25 | French | Compare |
v30 | 2024-04-25 | English | Compare |
v29 | 2024-04-25 | French | Compare |
v28 | 2024-04-25 | English | Compare |
v27 | 2024-04-25 | French | Compare |
v26 | 2024-04-25 | English | Compare |
v25 | 2024-03-27 | French | Compare |
v24 | 2024-03-27 | English | Compare |
v23 | 2023-12-28 | French | Compare |
v22 | 2023-12-28 | English | Compare |
v21 | 2023-11-16 | English | Compare |
v20 | 2023-11-15 | French | Compare |